LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
65 hedge funds and large institutions have $78.8M invested in La Jolla Pharmaceutical Company in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $82.1M → $78.8M (-$3.25M)
14% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 22
Holders
65
Holding in Top 10
2
Calls
$251K
Puts
$123K
Top Buyers
| 1 | +$720K | |
| 2 | +$491K | |
| 3 | +$461K | |
| 4 |
PAM
Premier Asset Management
Chicago,
Illinois
|
+$299K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$177K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$340K | |
| 3 | -$149K | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$118K |
| 5 |
GC
Grimes & Company
Westborough,
Massachusetts
|
-$102K |